- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Wellcome Says Farewell
16 April 2002 (All day)
LONDON--The Wellcome Trust, the charitable foundation that dominates biomedical research in the United Kingdom, has a year to find a new leader. Mike Dexter has announced that he will not extend his 5-year term when it expires in 2003.
Dexter, 57, was a respected cancer researcher and newly named director of the Paterson Institute in Manchester when he took the reins of the trust in 1998. Many observers say that under Dexter's leadership the $16 billion trust used its money to help save British science, often shaming the government into increasing its own support. Over the next 5 years the trust plans to spend about $4.3 billion, 85% in the United Kingdom, supporting biomedical research and related activities. "[Now] is the right time to begin the search for a successor," Dexter said in a statement about his decision not to seek an optional 2-year extension.
John Bell, head of Oxford University's Department of Clinical Medicine, calls Dexter's decision "a healthy way to run biomedical science. You find people of real quality, but they shouldn't be there forever. A lot was done in 5 years." Dexter has made no plans for what to do next and is "not going to think about it until next year," says a Wellcome spokesperson.
Observers give Dexter credit for charting the trust's recent course, which has included improving salaries and career paths for scientists and coaxing the government into matching an $800 million initiative for modernizing research infrastructure in U.K. universities after years of neglect.
But Dexter's work to secure the U.K.'s place in international genomics and large-scale biology may be his most significant accomplishment. Under his direction, the trust pumped hundreds of millions into the Sanger Centre, now Europe's largest sequencing and biological computing facility.
The Wellcome Trust